Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aguet

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetesB Wang, I André, A Gonzalez, et al.
The Journal of Experimental Medicine|June 1, 1995
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptorsL Fiette, C Aubert, U Müller, et al.
Cell|July 2, 1993
Mice devoid of PrP are resistant to scrapieH Büeler, A Aguzzi, A Sailer, et al.
Journal of Inflammation|January 1, 1995
Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptorR Kamijo, J Gerecitano, D Shapiro, et al.
The Journal of General Virology|August 1, 1987
Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virusT P Leist, M Aguet, M Hässig, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cellsC Billard, F Sigaux, S Castaigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responsesV E Schijns, B L Haagmans, E O Rijke, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.
Science (New York, N.Y.)|June 24, 1994
Functional role of type I and type II interferons in antiviral defenseU Müller, U Steinhoff, L F Reis, et al.
Immunity|June 15, 1999
Deficient T cell fate specification in mice with an induced inactivation of Notch1F Radtke, A Wilson, G Stark, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetesB Wang, I André, A Gonzalez, et al.
The Journal of Experimental Medicine|June 1, 1995
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptorsL Fiette, C Aubert, U Müller, et al.
Cell|July 2, 1993
Mice devoid of PrP are resistant to scrapieH Büeler, A Aguzzi, A Sailer, et al.
Journal of Inflammation|January 1, 1995
Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptorR Kamijo, J Gerecitano, D Shapiro, et al.
The Journal of General Virology|August 1, 1987
Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virusT P Leist, M Aguet, M Hässig, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cellsC Billard, F Sigaux, S Castaigne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1994
IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responsesV E Schijns, B L Haagmans, E O Rijke, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.
Science (New York, N.Y.)|June 24, 1994
Functional role of type I and type II interferons in antiviral defenseU Müller, U Steinhoff, L F Reis, et al.
Immunity|June 15, 1999
Deficient T cell fate specification in mice with an induced inactivation of Notch1F Radtke, A Wilson, G Stark, et al.
Pageof 10